Sagebrush Inn & Suites Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

NOTES:
This meeting occurs in 2017.
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.


Download Flyer

Twitter hashtag for this meeting: #KStgf

TGF-ß in Immunity, Inflammation and Cancer (A3)

Scientific Organizers: Wanjun Chen, Joanne E. Konkel and Richard A. Flavell


January 9—13, 2017

Sagebrush Inn & Suites, Taos, New Mexico, USA


Sponsored by BioLegend, Inc., EMD Serono Research and Development Institute, Inc. and Regeneron Pharmaceuticals, Inc.


Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
Scholarship Deadline: Sep 20, 2016 [details]
Discounted Abstract Deadline: Sep 20, 2016 [details]
Abstract Deadline: Oct 11, 2016 [details]
Discounted Registration Deadline: Nov 10, 2016 [details]

Click here to view Cancellation Policy

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2017-A3 "TGF-ß in Immunity, Inflammation and Cancer" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On September 20, 2016 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After September 20, 2016 until December 7, 2016 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
September 20, 2016 n/a
Discounted NON-STUDENT Registration
More details
Before and On November 10, 2016 795.00 USD
(includes 150.00 discount)
Regular NON-STUDENT Registration
More details
After November 10, 2016 945.00 USD
Discounted STUDENT Registration
More details
Before and On November 10, 2016 570.00 USD
(includes 150.00 discount)
Regular STUDENT Registration
More details
After November 10, 2016 720.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: September 20, 2016


Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is October 11, 2016)

Global Health Travel Award Deadline:


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: September 20, 2016


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: October 11, 2016


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is September 20, 2016)

Discounted Registration Deadline: November 10, 2016


Registration Fee: 795.00 USD* (includes 150.00 USD discount)
Student Registration Fee: 570.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 945.00 USD*
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Monday, January 9 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Friday, January 13 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Saturday, January 14 in order to fully experience the meeting.

MONDAY, JANUARY 9

16:00—20:00
Arrival and Registration

Sagebrush Lobby & Cantina
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Sagebrush Lobby & Cantina

TUESDAY, JANUARY 10

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
* Wanjun Chen, NIDCR, National Institutes of Health, USA

Rik Derynck, University of California, San Francisco, USA
TGF-beta Responses and Control of TGF-beta Responsiveness

09:00—11:30
TGF-beta Superfamily: Basic Mechanisms of Signal Transduction
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
* Richard A. Flavell, HHMI/Yale University School of Medicine, USA

Joan Massagué, Memorial Sloan Kettering Cancer Center, USA
Contextual Determinants of TGF-beta Signaling in Normal and Oncogenic Stem Cells

Coffee Break

Timothy A. Springer, Immune Disease Institute, Harvard University, USA
A Microglia Context Molecule for TGF-beta Required for Maintenance of Nervous System Function

Peter ten Dijke, Leiden University Medical Center, Netherlands
TGF-beta Receptor Signal Transduction in Breast Cancer

Aristidis Moustakas, Uppsala University, Sweden
Short Talk: Epigenetic Control and Micro-RNA Processing Connect TGFBeta to EMT and Tumor Cell Stemness

Ying E. Zhang, NCI, National Institutes of Health, USA
Short Talk: Direct Regulation of Alternative Splicing by SMAD3 is Essential to the Tumor-Promoting Role of TGF-beta

11:30—17:00
On Own for Lunch

11:30—13:00
Poster Setup

Chamisa Ballroom 2
13:00—22:00
Poster Viewing

Chamisa Ballroom 2
14:30—16:30
Workshop 1: TGF-ß in Fate Decisions and Cellular Functions

Chamisa Ballroom 1
* Akihiko Yoshimura, Keio University, Japan

* Yuzhang Wu, Third Military Medical University, China

Lakshmi Venkatraman, Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Studying the Dynamics of BMP9 and VEGF Signaling Crosstalk in Angiogenesis

Amina Dahmani, University of Montreal, Maisonneuve-Rosemont Hospital Research Center, Canada
Transforming Growth Factor-beta Programs Central-Memory Differentiation In Ex-Vivo Stimulated Human T Cells By Modulating Id3 Expression

Matthew Riese, Medical College of Wisconsin, USA
PECAM-1, a TGF-beta Receptor Binding Protein, Contributes to CD8+ T Cell Exhaustion

Fernando Souza-Fonseca-Guimaraes, Walter and Eliza Hall Institute, Australia
TGF-beta Inhibits NK Cell Activation and Cytotoxicity through Repression of the mTOR Pathway

Hongbo Hu, Sichuan University, China
Non-Canonical NF-kB: The Regulating Mechanism and Application in Cancer Immunology

Lopa Mishra, George Washington University, USA
An Integrated Approach Towards Dissecting the Dichotomy of the TGF-beta Pathway in Liver Inflammation and Cancer: Insights from a Human Stem Cell Syndrome, TCGA Analyses, and Mouse Models

Claire Gustafson, Stanford University, USA
Age-Related Changes in MicroRNA Expression Alter TGF-beta Signaling in Naïve CD8 T Cells during Human Immune Aging

Lily Huang, Regeneron Pharmaceutical, USA
Inhibition of Activin A Stops the Regrowth of Surgically Resected Heterotopic Bone in a Mouse Model of Fibrodysplasia Ossificans Progressiva and Indicates a New Potential Path to Therapy

16:30—17:00
Coffee Available

Chamisa Lobby
17:00—19:00
TGF-ß in Hematopoietic Stem Cells and Innate Immunity
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
* Howard L. Weiner, Brigham and Women’s Hospital, Harvard Medical School, USA

Stefan Karlsson, Lund University, Sweden
TGF-beta Signaling in Hematopoietic Stem Cells

Ursula Grohmann, University of Perugia, Italy
TGF-beta, Arg1, and IDO1: An Immunosuppressive Module at Work in Dendritic Cells

Herbert Strobl, Medical University Graz, Austria
TGF-beta and BMP Signaling in Langerhans Cells

Sylvain Perruche, Etablissement Français du Sang BFC, France
Short Talk: The Resolutive Factors Issued from Apoptotic Cell Clearance Allow the Termination of Ongoing Inflammation

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—22:00
Poster Session 1

Chamisa Ballroom 2

WEDNESDAY, JANUARY 11

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—11:00
TGF-ß in T Cells I
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
* John J. O'Shea, NIAMS, National Institutes of Health, USA

Richard A. Flavell, HHMI/Yale University School of Medicine, USA
TGF-beta Controls Th17 Plasticity and Maintains Intestinal Homeostasis

Vijay K. Kuchroo, Brigham and Women's Hospital, Harvard Medical School, USA
TGF-beta Induces Dominant Regulators that Promote Unidirectional Development of Foxp3+ Treg

Coffee Break

Wanjun Chen, NIDCR, National Institutes of Health, USA
TGF-beta Regulates Tregs and Bregs

Akihiko Yoshimura, Keio University, Japan
Induction of Stable TGF-ß-Mediated Regulatory T Cells by Epigenetic Modifications

Yisong Wan, University of North Carolina at Chapel Hill, USA
Short Talk: TGF-beta Signaling in Controlling Diverse T Cell Functions

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Chamisa Ballroom 2
13:00—22:00
Poster Viewing

Chamisa Ballroom 2
16:30—17:00
Coffee Available

Chamisa Lobby
17:00—19:00
TGF-ß in T Cells II
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
* Vijay K. Kuchroo, Brigham and Women's Hospital, Harvard Medical School, USA

John J. O'Shea, NIAMS, National Institutes of Health, USA
TGF-ß and MicroRNA in T Cell Plasticity

Sophie Lucas, Catholic University of Louvain, Belgium
GARP-Dependent Activation of TGF-beta1 Mediates Immunosuppression by Human and Mouse Tregs

Chen Dong, Tsinghua University, China
Smad2 and Smad4 in T Cells

Zihai Li, Medical University of South Carolina, USA
Short Talk: Cancer Promotion and Immune Tolerance Via A Novel gp96-GARP-TGF-beta Switch: Mechanisms and Opportunities

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—22:00
Poster Session 2

Chamisa Ballroom 2

THURSDAY, JANUARY 12

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—11:15
TGF-ß in Emerging Immune Cells
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
* Lucienne Chatenoud, INSERM U1151, Hôpital Necker-Enfants Malades, France

Shannon J. Turley, Genentech, Inc., USA
Regulation of Tumor Immunity by Stromal Cells

Yasmina Laouar, University of Michigan, USA
TGF-beta in Innate Cells Matters

Coffee Break

Joanne E. Konkel, University of Manchester, UK
TGF-beta in Regulatory T Cell Function

Julien C. Marie, INSERM/Cancer Research Center of Lyon, France
TGF-beta Signaling in Peculiar Innate Cells

Victor S. Cortez, Washington University in St. Louis, USA
Short Talk: Transforming Growth Factor-beta and Eomes Conversely Guide the Differentiation of ILC1 and NK Cells

Yuanming Xu, Northwestern University, USA
Short Talk: The E3 Ubiquitin Ligase Hrd1 Regulates TGF-beta Signaling Pathway to Maintain Regulatory T Cells Generation and Suppressive Function

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Chamisa Ballroom 2
13:00—22:00
Poster Viewing

Chamisa Ballroom 2
16:30—17:00
Coffee Available

Chamisa Lobby
17:00—19:00
TGF-ß in Mucosal Immunity and in Immune Tolerance
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
* Chen Dong, Tsinghua University, China

Howard L. Weiner, Brigham and Women’s Hospital, Harvard Medical School, USA
LAP-TGF-beta Immune Cells in Mucosal Immunity, Tolerance and Cancer

Hilde Cheroutre, La Jolla Institute for Allergy and Immunology, USA
A Give-and-Take Relation between TGF-beta and the Gut Environment Drives the CD4 CTL Fate

Yuzhang Wu, Third Military Medical University, China
Insight into Erythropoietin Signaling and Autoimmunity

Mark A. Travis, University of Manchester, UK
Short Talk: Human Blood Monocyte and Intestinal Macrophage Populations Regulate TGF-beta Activity via Expression of the Integrin Alphav beta8

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—22:00
Poster Session 3

Chamisa Ballroom 2

FRIDAY, JANUARY 13

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—11:15
TGF-ß in Inflammatory Diseases: Mechanisms and Immunotherapy
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
* Megan K. Levings, University of British Columbia, Canada
Mechanisms of Suppression by Human Regulatory T Cells

Lucienne Chatenoud, INSERM U1151, Hôpital Necker-Enfants Malades, France
CD3-Antibody, TGF-ß and Type I Diabetes

Coffee Break

Lingyun Sun, Nanjing University Medical School, China
TGF-beta in Mesenchymal Stem Cell-Mediated Immnoregulation in Autoimmune Diseases

Daniel H. Kaplan, University of Pittsburgh, USA
Stromal Cells Control Epithelial Residence of Dendritic Cells and Memory T Cells through Regulated Activation of Latent TGF-b

Danielle Smyth, University of Glasgow, UK
Short Talk: Identification of a Novel and Potent Mimic of TGF-beta Secreted by the Helminth Parasite Heligmosomoides Polygyrus

Vlad Senatorov, University of California, Berkeley, USA
Short Talk: Neuro-Inflammatory Astrocytic TGF-beta Signaling after Blood-Brain Barrier Disruption: A Novel Mechanism Underlying Age-Related Seizure Vulnerability and Cognitive Decline

11:15—17:00
On Own for Lunch

14:30—16:30
Workshop 2: TGF-ß in Inflammatory Diseases and Cancer

Chamisa Ballroom 1
* Joanne E. Konkel, University of Manchester, UK

* Lingyun Sun, Nanjing University Medical School, China

Gabriela Dveksler, Uniformed Services University of the Health Sciences, USA
Proteins Secreted from the Human Placenta Activate Latent TGF-b and Demonstrate Therapeutic Potential

Karen Laky, NIAID, National Institutes of Health, USA
TGFBR1M318R+/- Knock-In Mice Recapitulate the Immune Phenotypes of Loeys-Dietz Syndrome

Piotr Jachimczak, RealTVac, Germany
A Novel Strategy to Treat Advanced, Late-Stage Tumors with Real-Time Tumor Vaccination - RealTVac®

James Gulley, NCI, National Institutes of Health, USA
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGF-beta, in Advanced Solid Tumors

David F. Vincent, CRUK - Beatson Institute for Cancer Research, UK
Genetic Mouse Models of Bowel Cancer Reveal the Role of TGF-beta Signaling in Intestinal Stem Cell Homeostasis and Cancer

Shaopeng Yuan, Rockefeller University, USA
TGF-beta Responsive Tumor Stem Cell Development and Drug Resistance in Squamous Cell Carcinoma

16:30—17:00
Coffee Available

Chamisa Lobby
17:00—18:45
TGF-ß in Cancer: Signaling in Cancer Cells and Immunotherapy for Cancer
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
* Peter ten Dijke, Leiden University Medical Center, Netherlands

Julie Magarian Blander, Weill Cornell Medicine, Cornell University, USA
Apoptosis, Tissue Phagocytes in Immune Homeostasis, Inflammation and Cancer

Lalage M. Wakefield, NCI, National Institutes of Health, USA
Anti-TGF-beta Antibody Therapy: Lessons from Pre-Clinical Cancer Models

Karim A. Benhadji, Eli Lilly and Company, USA
Clinical Development of TGF-b Receptor Inhibitors in Cancer

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 12/09/2016

Chamisa Ballroom 1
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Chamisa Ballroom 2

SATURDAY, JANUARY 14

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

BioLegend, Inc. EMD Serono Research and Development Institute, Inc.
Regeneron Pharmaceuticals, Inc.
 

We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



We gratefully acknowledge additional support for this conference from:

Bio-Techne

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13AI126781-01

“Funding for this conference was made possible [in part] by 1R13AI126781-01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.”


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Eli Lilly and Company


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Assistant Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676